Predicting outcomes with pembrolizumab: a meta-analysis of pre-treatment hematological and clinical prognostic factors in advanced/metastatic urothelial carcinoma. Archivio Italiano di Urologia e Andrologia, [S. l.], v. 97, n. 2, 2025. DOI: 10.4081/aiua.2025.13880. Disponível em: https://www.pagepressjournals.org/aiua/article/view/13880. Acesso em: 21 apr. 2026.